Kraken Launches U.S.-Listed Stock & ETF Trading, Expanding Beyond Crypto
Commission-Free Trading on 11,000+ U.S.-Listed Stocks and ETFs Now Available to Select U.S. Clients CHEYENNE, Wyo.–(BUSINESS WIRE)–Kraken, one of the... Read more.
Losartan (CAS 114798-26-4) Industry Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 – Manufacturers, Market Prices, Patents, Down-stream Industries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Losartan (CAS 114798-26-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029”... Read more.
Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials
Findings Further Support the Safety Profile and Immunomodulatory Effects of ADI-100, Adimune’s Lead Therapeutic Candidate for Autoimmune Diseases MOUNTAIN VIEW,... Read more.
Wolters Kluwer CT Corporation to host webinar on effective business license management
Experts to offer insights on streamlining compliance processes and avoiding costly licensing missteps NEW YORK–(BUSINESS WIRE)–#CTcorporation–Experts... Read more.
REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment
Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS, identified ONA-255 drug target and currently leads the advisory board of Ona Therapeutics.... Read more.
Massive Bio Receives CNIL Certification for GDPR Compliance
BOCA RATON, Fla.–(BUSINESS WIRE)–Massive Bio holds certification from the French Data Protection Authority (CNIL), confirming its compliance with the... Read more.
Business Development Expert Josh Smith Joins Alliant Employee Benefits
California-based sales lead will direct business development activities across the western region IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance–Business... Read more.
Aulos Bioscience Doses First Patient in Phase 2 Cohort Evaluating AU-007 in Combination With Nivolumab for Second-Line Treatment of Melanoma
LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of immune-activating... Read more.
WRDS Honors University of Manchester with 2025 Innovation Award
PHILADELPHIA–(BUSINESS WIRE)–#academicresearch–Wharton Research Data Services (WRDS) announces the University of Manchester, Alliance Manchester... Read more.
Digimarc Recycle Earns Industrial Scale Validation in HolyGrail 2.0 Trials
Digimarc’s Advanced Digital Watermarking Technology Proven ‘Ready For Full Commercial Deployment’ BEAVERTON, Ore.–(BUSINESS WIRE)–Digimarc Corporation... Read more.